Statistics

Total Visits

Views
Myeloablative conditioning with intravenous busulfan in one daily dose and fludarabine (BUF) for HLA-identical sibling allogeneic HSCT in myeloid malignancies12

Select a period of time:

Number of views in the range

Views
Myeloablative conditioning with intravenous busulfan in one daily dose and fludarabine (BUF) for HLA-identical sibling allogeneic HSCT in myeloid malignancies8

Views

Views
May 20246
June 20240
July 20241
August 20240
September 20240
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom1
 

Top cities views

Views
Chicago4